Follow
Sean Avedissian
Title
Cited by
Cited by
Year
Vancomycin area under the curve and acute kidney injury: a meta-analysis
DM Aljefri, SN Avedissian, NJ Rhodes, MJ Postelnick, K Nguyen, ...
Clinical Infectious Diseases 69 (11), 1881-1887, 2019
1482019
HIV-1 integrase inhibitors: a comparative review of efficacy and safety
KK Scarsi, JP Havens, AT Podany, SN Avedissian, CV Fletcher
Drugs 80 (16), 1649-1676, 2020
892020
A review of the clinical pharmacokinetics of polymyxin B
SN Avedissian, J Liu, NJ Rhodes, A Lee, GM Pais, AR Hauser, ...
Antibiotics 8 (1), 31, 2019
802019
Population pharmacokinetics of polymyxin B in acutely ill adult patients
C Miglis, NJ Rhodes, SN Avedissian, CJ Kubin, MT Yin, BC Nelson, ...
Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01475-17, 2018
782018
Augmented renal clearance using population-based pharmacokinetic modeling in critically ill pediatric patients
SN Avedissian, E Bradley, D Zhang, JS Bradley, LH Nazer, TM Tran, ...
Pediatric Critical Care Medicine 18 (9), e388-e394, 2017
782017
Vancomycin‐induced kidney injury: animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention
GM Pais, J Liu, S Zepcan, SN Avedissian, NJ Rhodes, KJ Downes, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (5 …, 2020
632020
Population pharmacokinetics of intravenous polymyxin B from clinical samples
CJ Kubin, BC Nelson, C Miglis, MH Scheetz, NJ Rhodes, SN Avedissian, ...
Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01493-17, 2018
502018
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model
GM Pais, J Liu, SN Avedissian, D Hiner, T Xanthos, A Chalkias, E d˘Aloja, ...
Journal of antimicrobial chemotherapy 75 (5), 1228-1236, 2020
442020
Comparative performance of urinary biomarkers for vancomycin-induced kidney injury according to timeline of injury
GM Pais, SN Avedissian, JN O˘Donnell, NJ Rhodes, TP Lodise, ...
Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 00079-19, 2019
422019
Piperacillin-tazobactam added to vancomycin increases risk for acute kidney injury: fact or fiction?
SN Avedissian, GM Pais, J Liu, NJ Rhodes, MH Scheetz
Clinical infectious diseases 71 (2), 426-432, 2020
412020
Polymyxin B pharmacokinetics in adult cystic fibrosis patients
SN Avedissian, C Miglis, CJ Kubin, NJ Rhodes, MT Yin, S Cremers, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (7 …, 2018
412018
Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model
SN Avedissian, GM Pais, JN O˘Donnell, TP Lodise, J Liu, WC Prozialeck, ...
Journal of Antimicrobial Chemotherapy 74 (8), 2326-2334, 2019
392019
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
SR Dyavar, R Singh, R Emani, GP Pawar, VD Chaudhari, AT Podany, ...
Biomedicine & Pharmacotherapy 141, 111794, 2021
272021
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
S Deodhar, B Sillman, AN Bade, SN Avedissian, AT Podany, ...
Nature communications 13 (1), 3226, 2022
212022
Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies
JN O'Donnell, NJ Rhodes, CM Miglis, L Catovic, J Liu, C Cluff, G Pais, ...
International Journal of Antimicrobial Agents 51 (2), 239-243, 2018
21*2018
The Pharmacodynamic-Toxicodynamic Relationship of AUC and Cmax in Vancomycin-Induced Kidney Injury in an Animal Model
SN Avedissian, G Pais, J Liu, JN O˘Donnell, TP Lodise, M Neely, ...
Antimicrobial Agents and Chemotherapy 65 (3), 10.1128/aac. 01945-20, 2021
152021
Of rats and men: a translational model to understand vancomycin pharmacokinetic/toxicodynamic relationships
MH Scheetz, GM Pais, TP Lodise, SYC Tong, JS Davis, JN O˘Donnell, ...
Antimicrobial Agents and Chemotherapy 65 (10), 10.1128/aac. 01060-21, 2021
112021
Development of population and Bayesian models for applied use in patients receiving cefepime
J Liu, M Neely, J Lipman, F Sime, JA Roberts, PJ Kiel, SN Avedissian, ...
Clinical Pharmacokinetics 59, 1027-1036, 2020
112020
Use of simulation strategies to predict subtherapeutic meropenem exposure caused by augmented renal clearance in critically ill pediatric patients with sepsis
SN Avedissian, SM Skochko, J Le, S Hingtgen, H Harvey, EV Capparelli, ...
The journal of pediatric pharmacology and therapeutics 25 (5), 413-422, 2020
112020
Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU
SN Avedissian, NJ Rhodes, Y Kim, J Bradley, JL Valdez, J Le
Journal of Antimicrobial Chemotherapy 75 (1), 162-169, 2020
112020
The system can't perform the operation now. Try again later.
Articles 1–20